2013•China Modern MedicineRequires access

Application value of glycosylated hemoglobin in non-diabetic coronary heart disease individuals

Cheng Xiaodan

Abstract

Objective To explore the clinical value of glycosylated hemoglobin (HbA1c) in non-diabetic coronary heart disease individuals. Methods One hundred and ten cases with non-diabetic coronary heart disease (CHD) including 60 cases with acute coronary syndrome (ACS) and 50 cases with stable angina pectoris (SAP), and 50 cases of other diseases except diabetes and coronary heart disease were selected. The plasma levels of HbA1c in all groups were detected and analyzed. Results The level of HbA1c in CHD group was significantly higher than that in control group (P0.05), and level of HbA1c in ACS group was higher than that in SAP group (P0.05). Conclusion HbA1c is a marker of cardiovascular risk.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Medicine, Internal medicine, Coronary heart disease, Diabetes mellitus, Cardiology, Acute coronary syndrome, Hemoglobin, Angina